Expected values may fail in representing the distributions they summarize. This thesis investigates how this issue affects the evaluation of the design of an experiment, especially in clinical trials, when a hybrid Bayesian-frequentist approach is employed. We focus on the probability of success (PoS) of a test, which is originally (but not uniquely) defined as the expected value of the random power, ie the traditional power function of a test with respect to a design prior assigned to the parameter under scrutiny. We review and compare alternative definitions of PoS, we investigate the distributions they summarize (the random power and friends), and we provide a decision-theoretic look at the problem which leads to a unifying, uncontroversial quantification of success. We then go beyond clinical trials and hypothesis testing, and we study the Bayes risk as a synthesis of the random risk function in the point and set estimation classes of problems. Results, discussions and comparisons are supported by theoretical results and accompanied by biomedical examples and applications.

Random power and friends: hybrid Bayesian-frequentist approaches in clinical trials design / Mariani, Francesco. - (2025 Jan 27).

Random power and friends: hybrid Bayesian-frequentist approaches in clinical trials design

MARIANI, FRANCESCO
27/01/2025

Abstract

Expected values may fail in representing the distributions they summarize. This thesis investigates how this issue affects the evaluation of the design of an experiment, especially in clinical trials, when a hybrid Bayesian-frequentist approach is employed. We focus on the probability of success (PoS) of a test, which is originally (but not uniquely) defined as the expected value of the random power, ie the traditional power function of a test with respect to a design prior assigned to the parameter under scrutiny. We review and compare alternative definitions of PoS, we investigate the distributions they summarize (the random power and friends), and we provide a decision-theoretic look at the problem which leads to a unifying, uncontroversial quantification of success. We then go beyond clinical trials and hypothesis testing, and we study the Bayes risk as a synthesis of the random risk function in the point and set estimation classes of problems. Results, discussions and comparisons are supported by theoretical results and accompanied by biomedical examples and applications.
27-gen-2025
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1732487
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact